Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SERPINE1 | P05121 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6937115 | 0.85 | MAPT (0.63) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL11492952 | 0.82 | SERPINE1 (0.78) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL914479 | 0.82 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL5623940 | 0.79 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL6932811 | 0.79 | G6PD (0.58) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL1732418 | 0.78 | GAA (0.69) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL745596 | 0.78 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2APKMHSD17B10 | |
| SCHEMBL30473321 | 0.78 | GAA (0.69) | ALDH1A1MEN1KMT2APKMPOLB | |
| SCHEMBL30460505 | 0.78 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2APKMHSD17B10 | |
| SCHEMBL29400283 | 0.78 | GAA (0.69) | ALDH1A1MEN1KMT2APKMPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161846-A | Antistatic UV (ultraviolet) mucosa-reducing agent and preparation method thereof | 江苏斯瑞达材料技术股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| US-6280923-B1 | LIGHT-INSENSITIVE SILVER SALT OF AN ORGANIC CARBOXYLIC ACID; PHOTOSENSITIVE SILVER HALIDE; BINDER; ORGANIC REDUCING AGENT FOR SAID SUBSTANTIALLY LIGHT-INSENSITIVE SILVER SALT | AGFA-GEVAERT (BE) | 2001-08-28 | — | — | US | claimed |
| US-12570620-B2 | Covalent inhibitors of creatine kinase (CK) and uses thereof for treating and preventing cancer | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| CN-119161846-A | Antistatic UV (ultraviolet) mucosa-reducing agent and preparation method thereof | 江苏斯瑞达材料技术股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119161846-A | Antistatic UV (ultraviolet) mucosa-reducing agent and preparation method thereof | 江苏斯瑞达材料技术股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| US-20230399304-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | DANA-FARBER CANCER INSTITUTE, INC. | 2023-12-14 | — | — | US | disclosed |
| US-20230399304-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | DANA-FARBER CANCER INSTITUTE, INC. | 2023-12-14 | — | — | US | disclosed |
| US-20230399304-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | DANA-FARBER CANCER INSTITUTE, INC. | 2023-12-14 | — | — | US | disclosed |
| EP-4232161-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | Dana-Farber Cancer Institute, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-116323571-A | Covalent inhibitors of Creatine Kinase (CK) and their use for the treatment and prevention of cancer | 丹娜法伯癌症研究院 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022087433-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-04-28 | — | — | WO | disclosed |
| EP-0384893-A1 | Process for the preparation of asymmetrical 1,2-metal complex dyestuffs | CIBA-GEIGY AG (CH) | 1990-08-29 | — | — | EP | disclosed |
| US-4560744-A | FOR NYLON AND NATURAL POLYAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1985-12-24 | — | — | US | disclosed |
| US-4524123-A | POLYETHERSILOXANE COPOLYMERS, HIGH MOLECULAR WEIGHT POLYETHYLEN, AND EMULSIFIER | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1985-06-18 | — | — | US | disclosed |
| EP-0054230-B1 | MONOAZO DYESTUFFS AND USE AS IMAGE-FORMING DYESTUFFS IN COLOUR-PHOTOGRAPHIC REGISTRATION MATERIALS | Agfa-Gevaert AG (DE) | 1985-03-20 | — | — | EP | disclosed |
| EP-0037904-B1 | METAL-COMPLEX DYESTUFFS | BASF Aktiengesellschaft (DE) | 1983-12-28 | — | — | EP | disclosed |
| US-4396710-A | Photographic recording material with metal complexable, heterocyclic azo dye | AFGA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1983-08-02 | — | — | US | disclosed |
| EP-0054230-A2 | Monoazo dyestuffs and use as image-forming dyestuffs in colour-photographic registration materials | Agfa-Gevaert AG (DE) | 1982-06-23 | — | — | EP | disclosed |
| EP-0037904-A1 | Metal-complex dyestuffs | BASF Aktiengesellschaft (DE) | 1981-10-21 | — | — | EP | disclosed |
| US-4264494-A | Chromium complex dyestuffs for natural polyamides and synthetic nylons | BASF AKTIENGESELLSCHAFT (DE) | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570620-B2 | Covalent inhibitors of creatine kinase (CK) and uses thereof for treating and preventing cancer | CSNK1A1L, CKMT1A; CKMT1B, KHK | ALDH1A1 1714/4885MEN1 4864/4885KMT2A 476/4885 |
| US-20230399304-A1 | COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER | CKMT1A; CKMT1B, PHKG1, PCK1 | ALDH1A1 924/4885MEN1 4455/4885KMT2A 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.